GLENDALE, Calif., Feb. 9, 2017 /PRNewswire/ -- Apollo Medical Holdings, Inc. ("ApolloMed" or "the Company")
Key features of Apollo Care Connect 4.0 are:
- Real time communication between physicians/case managers and patients and their families - Integrates with and captures data from multiple EHRs, wearables and other devices - Vault of 70 self-monitoring Digital Care Plans, with particular focus on chronic, high-risk patients - User-friendly Care Plan Wizard to easily create and modify care plans without additional coding - Robust mobile platform with Chat, SMS Text, Push and Pop-up Notifications, and Email capabilities - Care Management Dashboard allows coaches/care managers to quickly focus on multiple conditions through automated messaging and alerts - Interactive Personal Health Assistant with decision support, recommendations, and actionable tasks - Gamification system incentivizes patients for positive behavior and lifestyle changes - Flexible platform that can be integrated with other internal and 3rd party analytical tools
Given Apollo Care Connect is not a stand-alone IT/Digital Health company but rather part of a value-based, provider-driven population health management company, we understand the needs and complexities of physicians, hospitals, payors, MSOs, IPAs, ACOs, patients and other stakeholders. We also understand the complexity, challenges and cost of technology implementation into the core of care delivery processes.
Therefore, we are pleased to offer Apollo Care Connect Base 4.0 Platform for only $10 per patient per year for select healthcare companies. It is our belief that the complexity and cost for continual provider/patient engagement should be lowered and part of daily use as we move more towards a consumer-involved US healthcare system.
Apollo Care Connect will be at HIMSS 2017 in Orlando, Florida from February 20 to 23. Please stop by for a demo and meet the team. If you are not attending HIMSS, please contact us for a product overview and complimentary platform access.
"Integrating technology, data and connectivity into clinical and risk-management processes is essential for value- based care companies," stated Gary Augusta, Chief Executive Officer of Apollo Care Connect, Inc. "Apollo Care Connect is a robust, cost-effective platform for any healthcare entity that wants to both care for and interact with patients. "
"It is important to not only have the back end product or case management system in place, but a powerful front end technology in the form of an interactive patient engagement tool," stated Diane Pham, M.D., Senior VP of Medical Informatics at Apollo Care Connect, Inc. "The ability to individualize and manage a patient's complex care plan in minutes, communicate real-time or to customize automated care, lab or behavioral alerts in a population are a few examples of how Apollo Care Connect differentiates itself from others."
About Apollo Medical Holdings, Inc.
Founded in 2001 and headquartered in Glendale, California, ApolloMed is an integrated population health management company committed to providing exceptional multi-disciplinary care in the communities it serves. ApolloMed is addressing the healthcare needs of its patients by leveraging its integrated healthcare delivery platform comprised of: ApolloMed Hospitalists, APA ACO (Next Generation ACO), ApolloMed ACO (MSSP Accountable Care Organization), Maverick Medical Group (Independent Physician Association), Apollo Care Connect, Apollo Medical Management and Apollo Palliative Services. ApolloMed strives to improve medical outcomes with high-quality, cost-efficient care. For more information, please visit www.apollomed.net
Forward Looking Statements
This press release may contain forward-looking statements, including information about management's view of future expectations, plans and prospects for Apollo Medical Holdings, Inc. ("the Company"). In particular, when used in the preceding discussion, the words "predicts," "believes," "expects," "intends," "seeks," "estimates," "plans," "anticipates," and similar conditional expressions or future or conditional verbs such as "will," "may," "might," "should," "would" and "could" are intended to identify forward-looking statements. In addition, our representatives may from time to time make oral forward-looking statements. Any such statements, other than those of historical fact, about an action, event or development, are forward-looking statements. Such statements are based on the current expectations and certain assumptions of the Company's management. Such statements are, therefore, subject to a variety of known and unknown risks, uncertainties and other factors, many of which are beyond the control of the Company, which could cause the actual results, performance or achievements of the Company, its subsidiaries and concepts to be materially different than those that may be expressed or implied in such statements or anticipated on the basis of historical trends. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, the Company's actual results, performance or achievements may vary materially from those described in the relevant forward-looking statement as being expected, anticipated, intended, planned, believed, sought, estimated or projected. Unknown or unpredictable factors also could have material adverse effects on the Company's future results. The forward-looking statements included herein are made only as of the date hereof. The Company cannot guarantee future results, levels of activity, performance or achievements. Accordingly, you should not place undue reliance on these forward-looking statements. Finally, the Company undertakes no obligation to update or revise these forward-looking statements to reflect the impact of circumstances or events that arise after the date the forward-looking statement was made, except as required by law, and also takes no obligation to update or correct information prepared by third parties that are not paid for by the Company. You should not place undue reliance on any forward-looking statement and should consider the uncertainties and risks discussed under Item 1A. "Risk Factors" of the Company's Annual Report on Form 10-K for the year ended March 31, 2016 and in any of the Company's other subsequent Securities and Exchange Commission filings.
FOR ADDITIONAL INFORMATION ApolloMed Gary Augusta 818-839-5200 or via email at firstname.lastname@example.org
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/apollo-care-connect-population-health-management-technology-platform-40-launched-300404856.html
SOURCE Apollo Medical Holdings, Inc.
Subscribe to our Free Newsletters!
Neuroblastoma is a very rare type of childhood cancer that develops in immature nerve cells ...
Video-electroencephalography monitoring is a diagnostic technique that records the electrical ...
Myomectomy is a surgery that is done to remove fibroids, which are non-cancerous growths of the ...View All